is there a shortage of semaglutide Maker Ozempic and Wegovy says the company working to make it more affordable Semaglutide Market Size, Share &

Abstract Background Semaglutide is a glucagon-like peptide-1 (GLP-1) analog treatment for type 2 diabetes (T2D) available in subcutaneous (s.c.) and oral formulations

Patients new to GLP-1 treatment often start at a low dose and increase the dosage as their bodies adjust

Front Physiol 13:1028486

[1] [3] The compounded nature of this product allows for individualized dosing and administration, which may be advantageous in clinical scenarios where standardized commercial products are not available or appropriate

Always follow your regular dosing schedule unless your doctor tells you otherwise

Others may struggle with the idea of long-term pharmacologic support for weight management